Bristlecone Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.92M | Buy |
|
|||||
|
2025
Q2 | $1.45M | Sell |
|
|||||
|
2025
Q1 | $1.61M | Sell |
|
|||||
|
2024
Q4 | $1.6M | Sell |
|
|||||
|
2024
Q3 | $1.98M | Buy |
|
|||||
|
2024
Q2 | $1.87M | Buy |
|
|||||
|
2024
Q1 | $1.6M | Buy |
|
|||||
|
2023
Q4 | $1.19M | Buy |
|
|||||
|
2023
Q3 | $1.07M | Hold |
|
|||||
|
2023
Q2 | $933K | Buy |
|
|||||
|
2023
Q1 | $673K | Sell |
|
|||||
|
2022
Q4 | $980K | Sell |
|
|||||
|
2022
Q3 | $876K | Buy |
|
|||||
|
2022
Q2 | $878K | Buy |
|
|||||
|
2022
Q1 | $504K | Sell |
|
|||||
|
2021
Q4 | $496K | Sell |
|
|||||
|
2021
Q3 | $718K | Hold |
|
|||||
|
2021
Q2 | $714K | Buy |
|
|||||
|
2021
Q1 | $560K | Sell |
|
|||||
|
2020
Q4 | $537K | Buy |
|
|||||
|
2020
Q3 | $469K | Buy |
|
|||||
|
2020
Q2 | $513K | Sell |
|
|||||
|
2020
Q1 | $459K | Sell |
|
|||||
|
2019
Q4 | $696K | Buy |
|
|||||
|
2019
Q3 | $339K | Sell |
|
|||||
|
2019
Q2 | $588K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $495K | Sell |
|
|||||
|
2018
Q3 | $465K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $401K | Sell |
|
|||||
|
2017
Q3 | $406K | Sell |
|
|||||
|
2017
Q2 | $399K | Hold |
|
|||||
|
2017
Q1 | $408K | Sell |
|
|||||
|
2016
Q4 | $369K | Sell |
|
|||||
|
2016
Q3 | $405K | Buy |
|
|||||
|
2016
Q2 | $386K | Sell |
|
|||||
|
2016
Q1 | $549K | Sell |
|
|||||
|
2015
Q4 | $698K | Buy |
|